The oversubscribed round was led by Venrex with participation from 8VC, Form Ventures, and several venture scout funds.
"With the adoption of AI in creative tools, the amount of creative work is now growing by 30% a year. For example, last year, more photographs were generated than have ever been taken by human photographers. So, we’ve been asking ourselves ‘what infrastructure is going to be needed to manage this volume of work?’. One problem that doesn’t scale well is issue checking – there’s no Grammarly for creative work and to date this tedious work is still done by eye. Beyond issue checking, we believe AI provides creatives with insights akin to accessing a panel of experts. We see the role of AI as enabling people’s creative processes, not replacing them"
The seed round was led by TX Ventures with participation from Form Ventures, Portfolio Ventures, Neosfer, and Core Angels Barcelona.
"After meeting with many banks and fintechs, it was clear that this problem was extended within the financial industry. So we started focusing on solving this and helping banks get access to better data, prioritising accuracy and security."
The London based healthtech startup secured backing from investors including Entrepreneur First and Form Ventures to expand its platform into clinical settings.
"Our technology is revolutionary. By combining cutting edge neuroscience and ethical, explainable AI, we have built a tool that can help people get an accurate diagnosis and effective treatment plan in place faster than ever before. It’s all about arming clinicians with the very best tools so that they can do the very best by their patients. We’re so grateful for the support our investors have shown us so far; and we look forward to this next stage of our journey as we look to optimise and expand our technology and get it in the hands of the people who need it most."
The seed round was led by Connect Ventures with participation from Form Ventures, Boost Capital, and angel investors.
"It’s fantastic to be working with such an exceptional partner, Connect Ventures, who share our vision of a world where each patient on every clinical trial is supported and heard throughout their journey"
AlbionVC led the seed round with participation from Vast Ventures and Form Ventures to support platform expansion and team growth.
"Over the last several years, we have seen a fintech consumer revolution and the provision of debt from businesses to consumers has skyrocketed. As a result, many businesses now have the power to choose where the line between good or poor financial health gets drawn for their customers. It is time for businesses to start drawing this line empathically. We are thrilled to be partnering with the Ophelos team as they rebuild the relationship between businesses and consumers."
.png)
